The aim of this study was to determine the response to recombinant human erythropoietin (rhEPO) in anemic pregnant women with heterozygous hemoglobinopathies.
Department of Obstetrics and Gynecology, Institute of Obstetric Research, Fetomaternal Hematology Unit, Zurich University Hospital, Zurich, Switzerland. gabriela.bencaiova@usz.ch
